Company profile

Umoja Biopharma

Privately held: no public share price (Private clinical-stage biotech (Seattle) developing in vivo CAR-T therapies (VivoVec platform); no IPO or public listing as of 2026, shares trade only on private secondary markets. Source: https://pitchbook.com/profiles/company/399704-05 and https://forgeglobal.com/umoja-biopharma_ipo/ Sources: https://clinicaltrials.gov/study/NCT07735546 Entity resolved by asset-pipeline-v2.)